The entire study cohort included 950 patients diagnosed with acute pancreatitis between 2008 and 2019, of whom 228 received human serum albumin infusion during hospitalization (Alb group), and the remaining did not (non-Alb group). This evidence concerns the gene ALB and acute pancreatitis.